Teresa Brophy Bair - 02 Jan 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Legal Officer
Signature
Teresa Bair
Issuer symbol
KURA
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
04 Jan 2024, 16:07:17 UTC
Previous filing
21 Feb 2023
Next filing
31 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Award $0 +46,250 +187% $0.000000 71,032 02 Jan 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +92,500 $0.000000 92,500 02 Jan 2024 Common Stock 92,500 $15.36 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28.
F2 Includes 1,657 shares acquired on May 17, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.
F3 This option vests in 48 equal monthly installments commencing on the grant date.